T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review

Circulation Research

Volumn 119, Issue 2, 2016, Pages 277-299

  Puntmann, Valentina O ^a   Peker, Elif ^a,b   Chandrashekhar, Y ^c   Nagel, Eike ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ANKARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiomyopathy; Clinical translation; ECV; Myocardium; Native T1; T1 mapping

Indexed keywords

GADOLINIUM;

CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR SPACE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL DISEASE; MYOCARDITIS; NONISCHEMIC CARDIOMYOPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T1 MAPPING; ANIMAL; CARDIOMYOPATHY; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; TRENDS;

ANIMALS; CARDIOMYOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE;

EID: 84978139047     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.307974     Document Type: Review

References (134)

1. Hinojar R, Botnar R, Kaski JC, Prasad S, Nagel E, Puntmann VO, Individualized cardiovascular risk assessment by cardiovascular magnetic resonance. Future Cardiol 2014 10 273 289. doi: 10.2217/fca.13.102
2. Valbuena-López S, Hinojar R, Puntmann VO, Cardiovascular magnetic resonance in cardiology practice: A Concise Guide to Image Acquisition and Clinical Interpretation. Revista Española de Cardiología (English Edition) 2016 69 202 210
3. White JA, Patel MR, The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin 2007 25 71 95, vi. doi: 10.1016/j.ccl.2007.02.003
4. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000 343 1445 1453. doi: 10.1056/NEJM200011163432003
5. Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P, Cowie MR, Pennell DJ, Prasad SK, Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011 124 1351 1360. doi: 10.1161/CIRCULATIONAHA.110.011346
6. Gulati A, Jabbour A, Ismail TF, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013 309 896 908. doi: 10.1001/jama.2013.1363
7. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U, Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004 109 1250 1258. doi: 10.1161/01.CIR.0000118493.13323.81
8. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ, Detection of myocardial damage in patients with sarcoidosis. Circulation 2009 120 1969 1977
9. Arbustini E, Narula N, Dec GW, The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol 2013 62 2046 2072. doi: 10.1016/j.jacc.2013.08.1644
10. Mewton N, Liu C-Y, Croisille P, Bluemke D, Lima JAC, Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011 57 891 903
11. Puntmann VO, Carr-White G, Jabbour A, International T1 Multicentre CMR Outcome Study T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. JACC Cardiovasc Imaging 2016 9 40 50. doi: 10.1016/j.jcmg.2015.12.001
12. Ridgway JP, Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson 2010 12 71. doi: 10.1186/1532-429X-12-71
13. Kellman P, Hansen MS, T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 2014 16 2. doi: 10.1186/1532-429X-16-2
14. Kellman P, Arai AE, Xue H, T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson 2013 15 56. doi: 10.1186/1532-429X-15-56
15. Higgins DM, Moon JC, Review of T1 mapping methods: comparative effectiveness including reproducibility issues. Curr Cardiovasc Imaging Rep 2014 7 9252
16. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S, T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 2013 70 664 670. doi: 10.1002/mrm.24867
17. McDiarmid AK, Broadbent DA, Higgins DM, Swoboda PP, Kidambi A, Ripley DP, Erhayiem B, Musa TA, Dobson LE, Greenwood JP, Plein S, The effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic resonance imaging. Quant Imaging Med Surg 2015 5 503 510. doi: 10.3978/j.issn.2223-4292.2015.04.07
18. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004 52 141 146. doi: 10.1002/mrm.20110
19. Puntmann VO, D'Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E, Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013 6 295 301. doi: 10.1161/CIRCIMAGING.112.000151
20. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S, Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012 14 42. doi: 10.1186/1532-429X-14-42
21. Liu A, Wijesurendra RS, Francis JM, Robson MD, Neubauer S, Piechnik SK, Ferreira VM, Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. JACC Cardiovasc Imaging 2016 9 27 36. doi: 10.1016/j.jcmg.2015.08.018
22. Nagel E, Puntmann VO, Is myocardial native T1 the one answer for all? JACC Cardiovasc Imaging 2016 9 37 39. doi: 10.1016/j.jcmg.2015.09.009
23. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, Puntmann VO, Standardization of T1 measurements with MOLLI in differentiation between health and disease-the ConSept study. J Cardiovasc Magn Reson 2013 15 78. doi: 10.1186/1532-429X-15-78
24. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010 12 69. doi: 10.1186/1532-429X-12-69
25. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU, Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Radiology 2006 238 1004 1012. doi: 10.1148/radiol.2382041903
26. Dabir D, Child N, Kalra A, Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014 16 69. doi: 10.1186/s12968-014-0069-x
27. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson 2012 14 26. doi: 10.1186/1532-429X-14-26
28. Rogers T, Puntmann VO, T1 mapping-beware regional variations. Eur Heart J Cardiovasc Imaging 2014 15 1302. doi: 10.1093/ehjci/jeu082
29. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB, Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013 15 92. doi: 10.1186/1532-429X-15-92
30. Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P, Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med 2012 67 1644 1655. doi: 10.1002/mrm.23153
31. Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N, Sibley CT, Kellman P, Arai AE, Bluemke DA, Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson 2011 13 75. doi: 10.1186/1532-429X-13-75
32. McDiarmid AK, Swoboda PP, Erhayiem B, Ripley DP, Kidambi A, Broadbent DA, Higgins DM, Greenwood JP, Plein S, Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla. J Cardiovasc Magn Reson 2015 17 6. doi: 10.1186/s12968-015-0112-6
33. Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno H Jr, Nadruz W Jr, Kwong R, Jerosch-Herold M, Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging 2013 6 134 141. doi: 10.1161/CIRCIMAGING.112.979815
34. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012 126 1206 1216. doi: 10.1161/CIRCULATIONAHA.111.089409
35. Kammerlander AA, Marzluf BA, Zotter-Tufaro C, Aschauer S, Duca F, Bachmann A, Knechtelsdorfer K, Wiesinger M, Pfaffenberger S, Greiser A, Lang IM, Bonderman D, Mascherbauer J, T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication. JACC Cardiovasc Imaging 2016 9 14 23. doi: 10.1016/j.jcmg.2015.11.002
36. Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH, Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging 2013 38 217 224. doi: 10.1002/jmri.23875
37. Piechnik SK, Ferreira VM, Lewandowski AJ, Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 2013 15 13. doi: 10.1186/1532-429X-15-13
38. Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, van der Geest RJ, Liu Y, Hundley WG, Gomes AS, Liu S, Nacif M, Bluemke DA, Lima JA, Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2013 62 1280 1287. doi: 10.1016/j.jacc.2013.05.078
39. von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, Wassmuth R, Greiser A, Schwenke C, Niendorf T, Schulz-Menger J, Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson 2013 15 53. doi: 10.1186/1532-429X-15-53
40. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU, Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007 58 34 40. doi: 10.1002/mrm.21272
41. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008 52 1574 1580. doi: 10.1016/j.jacc.2008.06.049
42. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, Mudd JO, van der Geest RJ, Lima JA, Halushka MK, Bluemke DA, T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 2012 265 724 732. doi: 10.1148/radiol.12112721
43. Mascherbauer J, Marzluf BA, Tufaro C, Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 2013 6 1056 1065. doi: 10.1161/CIRCIMAGING.113.000633
44. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M, Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013 6 373 383. doi: 10.1161/CIRCIMAGING.112.000192
45. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H, T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015 16 210 216. doi: 10.1093/ehjci/jeu183
46. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010 122 138 144. doi: 10.1161/CIRCULATIONAHA.109.930636
47. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendergast BD, Robson MD, Neubauer S, Moon JC, Myerson SG, Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013 99 932 937. doi: 10.1136/heartjnl-2012-303052
48. Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC, Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 2012 14 88. doi: 10.1186/1532-429X-14-88
49. de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, Pasquet A, Vancraeynest D, Pouleur A-C, Vanoverschelde J-LJ, Gerber BL, Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 2015 17 1268
50. Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ, Sohn DW, Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 2015 274 359 369. doi: 10.1148/radiol.14141120
51. Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ, Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 2015 16 14 22. doi: 10.1093/ehjci/jeu182
52. Caforio AL, Pankuweit S, Arbustini E, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013 34 2636 48, 2648a. doi: 10.1093/eurheartj/eht210
53. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Böhm M, Update on myocarditis. J Am Coll Cardiol 2012 59 779 792. doi: 10.1016/j.jacc.2011.09.074
54. Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M, Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol 2016 67 1800 1811. doi: 10.1016/j.jacc.2016.02.013
55. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R, American Heart Association; American College of Cardiology; European Society of Cardiology The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007 116 2216 2233. doi: 10.1161/CIRCULATIONAHA.107.186093
56. Lurz P, Eitel I, Adam J, Steiner J, Grothoff M, Desch S, Fuernau G, de Waha S, Sareban M, Luecke C, Klingel K, Kandolf R, Schuler G, Gutberlet M, Thiele H, Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012 5 513 524. doi: 10.1016/j.jcmg.2011.11.022
57. Hinojar R, Nagel E, Puntmann VO, T1 mapping in myocarditis-headway to a new era for cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther 2015 13 871 874. doi: 10.1586/14779072.2015.1051035
58. Friedrich MG, Sechtem U, Schulz-Menger J, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009 53 1475 1487. doi: 10.1016/j.jacc.2009.02.007
59. Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H, Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012 59 1604 1615. doi: 10.1016/j.jacc.2012.01.007
60. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE, Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012 33 1268 1278. doi: 10.1093/eurheartj/ehr481
61. Dall'Armellina E, Ferreira VM, Kharbanda RK, Prendergast B, Piechnik SK, Robson MD, Jones M, Francis JM, Choudhury RP, Neubauer S, Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction. JACC Cardiovasc Imaging 2013 6 739 742. doi: 10.1016/j.jcmg.2012.11.020
62. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S, T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013 6 1048 1058. doi: 10.1016/j.jcmg.2013.03.008
63. Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu CY, McCrohon J, Higgins DM, Carr-White G, Mayr M, Nagel E, Puntmann VO, Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 2015 8 37 46. doi: 10.1016/j.jcmg.2014.07.016
64. Radunski UK, Lund GK, Stehning C, Schnackenburg B, Bohnen S, Adam G, Blankenberg S, Muellerleile K, CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 2014 7 667 675. doi: 10.1016/j.jcmg.2014.02.005
65. Bohnen S, Radunski UK, Lund GK, Kandolf R, Stehning C, Schnackenburg B, Adam G, Blankenberg S, Muellerleile K, Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ Cardiovasc Imaging 2015 8 e003073. doi: 10.1161/CIRCIMAGING.114.003073
66. Isted A, Grigoratos C, Bratis K, Carr-White G, Nagel E, Puntmann VO, Native T1 in deciphering the reversible myocardial inflammation in cardiac sarcoidosis with anti-inflammatory treatment. Int J Cardiol 2016 203 459 462. doi: 10.1016/j.ijcard.2015.10.199
67. Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD, Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. JACC Cardiovasc Imaging 2015 8 526 536. doi: 10.1016/j.jcmg.2014.12.025
68. Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD, Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis-a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 2014 16 21. doi: 10.1186/1532-429X-16-21
69. Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, Hancock G, Beak P, Tajar A, Piechnik SK, Schneider JE, Angus B, Clarke K, Dorrell L, Neubauer S, Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013 128 814 822. doi: 10.1161/CIRCULATIONAHA.113.001719
70. Tham EB, Haykowsky MJ, Chow K, Spavor M, Kaneko S, Khoo NS, Pagano JJ, Mackie AS, Thompson RB, Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. J Cardiovasc Magn Reson 2013 15 48. doi: 10.1186/1532-429X-15-48
71. Perk J, De Backer G, Gohlke H, European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012 33 1635 1701. doi: 10.1093/eurheartj/ehs092
72. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006 113 1807 1816. doi: 10.1161/CIRCULATIONAHA.106.174287
73. Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 2013 10 15 26. doi: 10.1038/nrcardio.2012.158
74. Hill JA, Olson EN, Cardiac plasticity. N Engl J Med 2008 358 1370 1380. doi: 10.1056/NEJMra072139
75. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ, Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003 108 54 59. doi: 10.1161/01.CIR.0000078641.19365.4C
76. Hinojar R, Fernández-Golfín C, Zamorano JL, Imaging in HF-PEF with cardiovascular magnetic resonance. Curr Cardiovasc Imaging Rep 2015 8 7
77. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ, Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011 57 821 828. doi: 10.1016/j.jacc.2010.06.062
78. Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, Ghoshhajra BB, Kwong RY, CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 2013 6 944 954. doi: 10.1016/j.jcmg.2013.05.013
79. Leyva F, Taylor RJ, Foley PW, Umar F, Mulligan LJ, Patel K, Stegemann B, Haddad T, Smith RE, Prasad SK, Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 2012 60 1659 1667. doi: 10.1016/j.jacc.2012.05.054
80. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW, ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2013 61 1318 1368. doi: 10.1016/j.jacc.2012.12.017
81. Authors/Task Force members McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Authors/Task Force members ESC Committee for Practice Guidelines (CPG) Document Reviewers ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 2014 14 803 869
82. Xie M, Burchfield JS, Hill JA, Pathological ventricular remodeling: therapies: part 2 of 2. Circulation 2013 128 1021 1030. doi: 10.1161/CIRCULATIONAHA.113.001879
83. Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS, Kaye DM, Taylor AJ, Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol 2014 63 1112 1118. doi: 10.1016/j.jacc.2013.10.084
84. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E, Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013 6 475 484. doi: 10.1016/j.jcmg.2012.08.019
85. Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S, Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012 5 726 733. doi: 10.1161/CIRCIMAGING.112.976738
86. Mordi I, Carrick D, Bezerra H, Tzemos N, T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 2016 17 797 803. doi: 10.1093/ehjci/jev216
87. Fontana M, Banypersad SM, Treibel TA, Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 2014 7 157 165. doi: 10.1016/j.jcmg.2013.10.008
88. Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Moon JC, Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013 6 34 39. doi: 10.1161/CIRCIMAGING.112.978627
89. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC, Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013 6 488 497. doi: 10.1016/j.jcmg.2012.11.013
90. Jellis CL, Sacre JW, Wright J, Jenkins C, Haluska B, Jeffriess L, Martin J, Marwick TH, Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2014 15 776 786. doi: 10.1093/ehjci/jeu013
91. Sado DM, Maestrini V, Piechnik SK, Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J Magn Reson Imaging 2015 41 1505 1511. doi: 10.1002/jmri.24727
92. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M, Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010 3 727 734. doi: 10.1161/CIRCIMAGING.108.842096
93. Dusenbery SM, Jerosch-Herold M, Rickers C, Colan SD, Geva T, Newburger JW, Powell AJ, Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol 2014 63 1778 1785. doi: 10.1016/j.jacc.2013.11.066
94. Elliott PM, Anastasakis A, Borger MA, 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy. Revista Española de Cardiología (English Edition) 2015 68 63
95. Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, González A, Colan SD, Seidman JG, Díez J, Seidman CE, Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010 363 552 563. doi: 10.1056/NEJMoa1002659
96. Dorn GW II, The fuzzy logic of physiological cardiac hypertrophy. Hypertension 2007 49 962 970. doi: 10.1161/HYPERTENSIONAHA.106.079426
97. Lazzeroni D, Rimoldi O, Camici PG, From left ventricular hypertrophy to dysfunction and failure. Circ J 2016 80 555 564. doi: 10.1253/circj.CJ-16-0062
98. Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA, The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012 14 17. doi: 10.1186/1532-429X-14-17
99. Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, Schulz-Menger J, Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009 53 284 291. doi: 10.1016/j.jacc.2008.08.064
100. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H, Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010 56 875 887. doi: 10.1016/j.jacc.2010.05.007
101. Chan RH, Maron BJ, Olivotto I, Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 2014 130 484 495. doi: 10.1161/CIRCULATIONAHA.113.007094
102. Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY, T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging 2013 6 415 422. doi: 10.1161/CIRCIMAGING.112.000333
103. Brouwer WP, Baars EN, Germans T, de Boer K, Beek AM, van der Velden J, van Rossum AC, Hofman MB, In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2014 16 28. doi: 10.1186/1532-429X-16-28
104. Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ, A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Eur Heart J Cardiovasc Imaging 2014 15 1108 1116. doi: 10.1093/ehjci/jeu077
105. Hinojar R, Varma N, Child N, T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging 2015 8 e003285. doi: 10.1161/CIRCIMAGING.115.003285
106. Sado DM, White SK, Piechnik SK, Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013 6 392 398. doi: 10.1161/CIRCIMAGING.112.000070
107. Pica S, Sado DM, Maestrini V, Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014 16 99. doi: 10.1186/s12968-014-0099-4
108. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ, Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005 111 186 193. doi: 10.1161/01.CIR.0000152819.97857.9D
109. Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, Piechnik SK, Whelan CJ, Herrey AS, Gillmore JD, Lachmann HJ, Wechalekar AD, Hawkins PN, Moon JC, T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 2015 36 244 251. doi: 10.1093/eurheartj/ehu444
110. Schelbert EB, Piehler KM, Zareba KM, Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage. J Am Heart Assoc 2015 4 e002613. doi: 10.1161/JAHA.115.002613
111. Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB, Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2014 35 657 664. doi: 10.1093/eurheartj/eht193
112. Puntmann VO, Arroyo Ucar E, Hinojar Baydes R, Ngah NB, Kuo YS, Dabir D, Macmillan A, Cummins C, Higgins DM, Gaddum N, Chowienczyk P, Plein S, Carr-White G, Nagel E, Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension 2014 64 762 768. doi: 10.1161/HYPERTENSIONAHA.114.03928
113. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, FAME Study Investigators Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009 360 213 224. doi: 10.1056/NEJMoa0807611
114. Hussain ST, Paul M, Plein S, McCann GP, Shah AM, Marber MS, Chiribiri A, Morton G, Redwood S, MacCarthy P, Schuster A, Ishida M, Westwood MA, Perera D, Nagel E, Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson 2012 14 65. doi: 10.1186/1532-429X-14-65
115. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN, Meta-Analysis Global Group in Chronic Heart Failure Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013 34 1404 1413. doi: 10.1093/eurheartj/ehs337
116. Yancy CW, Jessup M, Bozkurt B, WRITING COMMITTEE MEMBERS; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013 128 e240 e327. doi: 10.1161/CIR.0b013e31829e8776
117. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S, Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012 14 15. doi: 10.1186/1532-429X-14-15
118. Kali A, Choi EY, Sharif B, Kim YJ, Bi X, Spottiswoode B, Cokic I, Yang HJ, Tighiouart M, Conte AH, Li D, Berman DS, Choi BW, Chang HJ, Dharmakumar R, Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions. JACC Cardiovasc Imaging 2015 8 1019 1030. doi: 10.1016/j.jcmg.2015.04.018
119. Abonnenc M, Nabeebaccus AA, Mayr U, Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res 2013 113 1138 1147. doi: 10.1161/CIRCRESAHA.113.302400
120. Sutton MG, Sharpe N, Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000 101 2981 2988
121. Look DC, Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970 41 250
122. Kvernby S, Warntjes MJ, Haraldsson H, Carlhäll CJ, Engvall J, Ebbers T, Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J Cardiovasc Magn Reson 2014 16 102. doi: 10.1186/s12968-014-0102-0
123. Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA, T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys 2005 32 1738 1746. doi: 10.1118/1.1921668
124. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB, Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med 2014 71 2082 2095. doi: 10.1002/mrm.24878
125. Roujol S, Weingärtner S, Foppa M, Chow K, Kawaji K, Ngo LH, Kellman P, Manning WJ, Thompson RB, Nezafat R, Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 2014 272 683 689. doi: 10.1148/radiol.14140296
126. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC, T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013 6 955 962. doi: 10.1016/j.jcmg.2013.01.011
127. Brooks J, Kramer CM, Salerno M, Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. J Magn Reson Imaging 2013 38 1591 1595. doi: 10.1002/jmri.24078
128. Chin CW, Semple S, Malley T, White AC, Mirsadraee S, Weale PJ, Prasad S, Newby DE, Dweck MR, Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014 15 556 565. doi: 10.1093/ehjci/jet245
129. Singh A, Horsfield MA, Bekele S, Khan JN, Greiser A, McCann GP, Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging 2015 16 763 770. doi: 10.1093/ehjci/jev007
130. Kuruvilla S, Janardhanan R, Antkowiak P, Keeley EC, Adenaw N, Brooks J, Epstein FH, Kramer CM, Salerno M, Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 2015 8 172 180. doi: 10.1016/j.jcmg.2014.09.020
131. Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V, Barison A, Patel V, Herrey AS, Davies C, Caulfield MJ, Petersen SE, Moon JC, Extracellular volume quantification in isolated hypertension-changes at the detectable limits? J Cardiovasc Magn Reson 2015 17 1031
132. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ, Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 2012 14 76. doi: 10.1186/1532-429X-14-76
133. Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD, Diffuse myocardial fibrosis is associated with impaired myocardial strain and disease activity in rheumatoid arthritis: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014 16 P292. doi: 10.1186/1532-429X-16-S1-P292
134. Neilan TG, Pena-Herrera D, Coelho-Filho OR, Jerosch-Herold M, Moslehi J, Kwong R, Left ventricular mass by cardiac magnetic resonance imaging and adverse cardiovascular outcomes in patients treated with anthracycline-based chemotherapy. J Cardiovasc Magn Reson 2012 14 O30